tirzepatide graph versus Semaglutide Once Weekly in Patients with Type 2 Diabetes Retatrutide vs Tirzepatide- Which Weight

The maximum recommended dosage is 70 mg once daily [see Clinical Studies (14.2)]

Analysis of the SELECT data showed that: Participants on semaglutide had significant reductions in CRP and other inflammatory biomarkers The cardiovascular benefit was only partially explained by weight loss, with inflammation reduction likely playing an important independent role Benefits were observed even in participants who achieved relatively modest weight loss (9) This suggests that semaglutides ability to reduce inflammation may be one of the key mechanisms behind its cardiovascular protection

This is why major obesity guidelines recommend long-term or indefinite GLP-1 therapy for eligible candidates

it does not show that adding them beyond adequacy pulls fat out of an already-nourished body

Lifestyle changes (diet and exercise) greatly impact outcomes